Works matching IS 10031057 AND DT 2024 AND VI 33 AND IP 3

Results: 12

The research group of Prof. Houhua Li developed a new method for constructing structural units of natural products and its application in total synthesis.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 289
Publication type:: Article

The research group of Prof. Qing Xia and Dr. Yujie Shi collaborated to improve the efficacy of the gene codon expansion system in the treatment of nonsense mutation diseases using oral ionic liquids-unnatural amino acid.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 285
Publication type:: Article

The research group of Prof. Ning Jiao developed a new strategy for catalytic conversion of mixed polyolefins under mild atmospheric pressure.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 283
Publication type:: Article

The research group of Prof. Qi Sun has made new progress in the development of allosteric activation of a7 nicotinic acetylcholine receptors for the improvement of cognitive deficits.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 281
Publication type:: Article

The research group of Prof. Qi Sun has made new progress in the development of allosteric activation of a7 nicotinic acetylcholine receptors for the improvement of cognitive deficits.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 278
Publication type:: Article

Exploring the mechanism of Mie-you decoction "homotherapy for heteropathy" to chronic atrophic gastritis and gastric ulcer using network pharmacologymolecular docking.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 258, doi. 10.5246/jcps.2024.03.021

By:

Siyu Wang;
Shuwei Zhou;
Bin Yu

Publication type:

Article

Analyzing the mechanism and experimental validation of Astilbe chinensis in the treatment of rheumatoid arthritis through network pharmacology.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 247, doi. 10.5246/jcps.2024.03.020

By:

Ying Chen;
Haixia Ying;
Tingting Cai;
Yunling Xu

Publication type:

Article

Effects of Shuxuetong combined with butylphthalide on neurological function and inflammatory response in patients with acute ischemic stroke.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 240, doi. 10.5246/jcps.2024.03.019

By:

Kunang Li;
Dongsheng Lu;
Yiyang Pan;
Yan Le;
Huan Yan;
Hao Fu;
Yindan Li;
Jinji Yang;
Miao Qu

Publication type:

Article

GAS5, as the ceRNA of miR-223-3p, mediates pyroptosis and inhibits the proliferation of brain glial cells U87, and quercetin can enhance its effect.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 229, doi. 10.5246/jcps.2024.03.018

By:

Yanqiang Sun;
Hongliang Li;
Kangxue Chen;
Jie Li;
Zhonglei Sun

Publication type:

Article

Formononetin inhibits benign prostatic hyperplasia through estrogen receptors.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 215, doi. 10.5246/jcps.2024.03.017

By:

Xiaohang Wang;
Le Wang;
Luanjuan Xiao;
Chunbin Lu

Publication type:

Article

Enhanced protective effects of naringenin on elastase-induced mouse abdominal aortic aneurysm through nanoliposome delivery.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 201, doi. 10.5246/jcps.2024.03.016

By:

Du Chen;
Maomao Yu;
Qingyi Zhang;
Rui Hu;
Xiqiao Zhou;
Bei Ta;
Youqun Lu;
Rong Qi

Publication type:

Article

Polymer-lipid nanoparticles enhance liver-targeted delivery of therapeutic base editor plasmid for the treatment of hereditary tyrosinemia type 1 (HT-1).

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 3, p. 189, doi. 10.5246/jcps.2024.03.015

By:

Datong Gao;
Meng Lin;
Yiwei Peng;
Jiajia Li;
Yiliang Yang;
Yulu Teng;
Siyu Chen;
Wen Sun;
Zinan W1;
Quan Yu;
Zhenzhen Yang;
Yanxia Zhou;
Xinru Li;
Xianrong Qi

Publication type:

Article